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CNNM2, Encoding a Basolateral Protein
Required for Renal Mg2þ Handling, Is Mutated
in Dominant Hypomagnesemia
Marchel Stuiver,1,2 Sergio Lainez,3 Constanze Will,1,2 Sara Terryn,4 Dorothee Gu¨nzel,5 Huguette Debaix,4
Kerstin Sommer,1,2 Kathrin Kopplin,1,2 Julia Thumfart,1,2 Nicole B. Kampik,6 Uwe Querfeld,1,2
Thomas E. Willnow,7 Vladimı´r Nemec,8 Carsten A. Wagner,6 Joost G. Hoenderop,3 Olivier Devuyst,4,6
Nine V.A.M. Knoers,9 Rene´ J. Bindels,3 Iwan C. Meij,7,10 and Dominik Mu¨ller1,2,10,*
Familial hypomagnesemia is a rare human disorder caused by renal or intestinal magnesium (Mg2þ) wasting, which may lead to symp-
toms of Mg2þ depletion such as tetany, seizures, and cardiac arrhythmias. Our knowledge of the physiology of Mg2þ (re)absorption,
particularly the luminal uptake of Mg2þ along the nephron, has benefitted from positional cloning approaches in families with Mg2þ
reabsorption disorders; however, basolateral Mg2þ transport and its regulation are still poorly understood. Here, by using a candidate
screening approach, we identified CNNM2 as a gene involved in renal Mg2þ handling in patients of two unrelated families with unex-
plained dominant hypomagnesemia. In the kidney, CNNM2was predominantly found along the basolateral membrane of distal tubular
segments involved in Mg2þ reabsorption. The basolateral localization of endogenous and recombinant CNNM2 was confirmed in
epithelial kidney cell lines. Electrophysiological analysis showed that CNNM2 mediated Mg2þ-sensitive Naþ currents that were signif-
icantly diminished inmutant protein and were blocked by increased extracellular Mg2þ concentrations. Our data support the findings of
a recent genome-wide association study showing the CNNM2 locus to be associated with serum Mg2þ concentrations. The mutations
found in CNNM2, its observed sensitivity to extracellular Mg2þ, and its basolateral localization signify a critical role for CNNM2 in
epithelial Mg2þ transport.Introduction
Magnesium (Mg2þ) plays a crucial role in many biological
processes such as enzyme and muscular function and
neuronal transmission. In adults, the normal serum
Mg2þ concentration ranges from 0.7 to 1.2 mmol/l.
Low levels of serum Mg2þ may be asymptomatic and go
unnoticed for a long time but may also cause tetany,
convulsions, cardiac arrhythmias, and various metabolic
abnormalities.
Mg2þ homeostasis is primarily regulated by intestinal
absorption and renal reabsorption involving a combina-
tion of paracellular and transcellular epithelial transport
pathways.1 As a result of screening of familial cases of
hypomagnesemia, several genes involved in renal Mg2þ
handling in both the paracellular and the transcellular
pathways have been discovered. For example, the tight
junction proteins claudin-16 (CLDN16 [MIM 603959])
and claudin-19 (CLDN19 [MIM 610036]) are mutated in
recessive familial hypomagnesemia with hypercalciuria
and nephrocalcinosis (FHHNC, [MIM 248250,
248190]).2,3 They are primarily involved in the paracellular
pathway, either, as initially suggested, by forming a selec-
tive permeability for Mg2þ and Ca2þ or, as more recently1Department of Pediatric Nephrology, Charite´ Universita¨tsmedizin Berlin, 133
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The Ameriproposed, by altering the driving force for reabsorption
of divalent cations by selective back-leakage of Naþ or by
altering Cl secretion.2,4–6 A key protein in the transcellu-
lar pathway is the epithelial Mg2þ channel TRPM6 (MIM
607009), which, when mutated, causes recessive hypo-
magnesemia with secondary hypocalcemia (HSH [MIM
602014]).7,8 Other genes mutated in human renal Mg2þ
wasting disorders, such as FXYD2 (MIM 601814, associated
with dominant renal hypomagnesemia [MIM 154020]),
EGF (MIM 131530, associated with recessive renal hypo-
magnesemia [MIM 611718]), KCNA1 (MIM 176260, associ-
ated with dominant myokymia with hypomagnesemia
[MIM 160120]), and HNF1B (MIM 189907, associated
with dominant renal cysts and diabetes syndrome [MIM
137920]) are also thought to be involved in transcellular
Mg2þ reabsorption.9–12 Whereas the apical entry pathway
for Mg2þ in the renal distal convoluted tubule (DCT)
formed by TRPM6 is relatively well characterized,13 the
molecular identity of basolateral extrusion mechanisms
for Mg2þ remain elusive.
We recently generated mice lacking claudin-16 to gain
insights into pathways relevant for renal Ca2þ and Mg2þ
handling.14 Cldn16-deficient mice displayed renal Ca2þ
and Mg2þ wasting as well as alterations in the renal53 Berlin, Germany; 2Center for Cardiovascular Research, Charite´ Universi-
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Figure 1. Pedigrees of Families and CNNM2 Mutations
(A) Pedigrees of families A (left) and B (right) and partial electropherograms of CNNM2 of the index patients. Filled symbols represent
affected individuals and index patients are indicated with a ‘‘P’’ and arrow. In the electropherograms, the mutations are indicated by
an arrow and the nucleotide changes and resulting effect on the protein are shown.
(B) Localization of the mutations in the predicted secondary structure of CNNM2. The predicted transmembrane domains are indicated
in green and the CBS domains in pink. The ancient conserved domain is boxed and the mutations are indicated with an asterisk.
(C) Conservation of human CNNM2 Thr568 in CNNM family members and in orthologs from mammals to bacteria. The amino acid
sequence of human CNNM2 (in bold) is aligned with its three human family members and six orthologs around Thr568 (boxed in
red). The upper ruler refers to the human CNNM2 amino acid positions. Conservation is shown below the sequences, following Clus-
talW convention (asterisk, invariant; colon, highly similar).transcriptome as shown by microarray analysis. Some of
the differentially expressed mRNAs encode proteins well
known for their involvement in renal Ca2þ and Mg2þ
handling, such as the epithelial Ca2þ and Mg2þ entry
channels TRPV5 and TRPM6 and the basolateral Naþ/
Ca2þ exchanger. In addition, we identified other, not
well-characterized upregulated transcripts, one of which
encodes CNNM2 (previously known as ACDP2).14 The
Cnnm2 transcript caught our interest because it has been
shown to be upregulated in mice kept on a low-Mg2þ
diet and in mouse DCT cells grown in low-Mg2þ-contain-
ing media.15 Moreover, when expressed in Xenopus laevis
oocytes, CNNM2 induced the transport of a range of
divalent cations, including Mg2þ but not Ca2þ.15
In the present study, we investigated CNNM2 (MIM
607803) as a candidate gene for unresolved human Mg2þ
wasting phenotypes and identified mutations in two unre-
lated families with dominant hypomagnesemia.Subjects and Methods
Patients
Informed consent to participate in this study was obtained from
the patients and their participating relatives. The procedures
followed were in accordance with the standards of the medical
ethics committee of each participating institution.334 The American Journal of Human Genetics 88, 333–343, March 1Family A
Details of the index patient and her father have been extensively
described elsewhere.16 In brief, in both individuals (Figure 1A,
left), severely lowered serum Mg2þ values were determined
before oral Mg2þ supplementation was started (0.46 mmol/l
and 0.51 mmol/l in father and daughter, respectively [normal
0.70–1.15 mmol/l]). For the father, a detailed urinary examination
was performed prior to the start of Mg2þ supplementation. Ca2þ
was found to be in the low to normal range 0.05–0.10 Ca2þ/
creatinine molar ratio, normal 0.06–0.45) and his urinary Mg2þ
excretion was in the normal range (0.1–0.2 Mg2þ/creatininemolar
ratio, normal 0.2–0.3). In view of the low serum Mg2þ levels,
normal urinary Mg2þ excretion suggests a renal defect in Mg2þ
reabsorption. The age of onset of symptoms was variable among
the two family members: onset was 15 years of age for the father,
whereas the index patient was hospitalized for being symptomatic
in the first two years of life.
Family B
The index patient in family B (Figure 1A, right) was admitted to
the hospital at 16 years of age. He suffered from weakness of the
limbs, vertigo, and headaches. Laboratory examination revealed
a low serum Mg2þ of 0.36 mmol/l and a urinary Ca2þ excretion
of 2.7 mmol/24 hr, which is in the low to normal range (normal
2.5–8.0). All other measured values were normal (including serum:
Naþ, 143 mmol/l [normal 136–146]; Kþ, 4.5 mmol/l [normal
3.5–5.1]; Ca2þ, 2.47 mmol/l [normal 2.15–2.60]; urine: urea
271 mmol/24 hr [normal 150–500]; creatinine, 10.1 mmol/24 hr
[normal 4.5–18]; Naþ, 125 mmol/24 hr [normal 40–220]; Kþ,
40 mmol/24 hr [normal 25–125]; Cl, 142 mmol/24 hr [normal1, 2011
110–250]; Mg2þ, 6.7 mmol/24 hr [normal 2.5–8.5]). Again, the
combination of normal urinary Mg2þ excretion and low serum
Mg2þ levels points to a renal Mg2þ reabsorption defect. Only
serum values were available for the mother. She did not display
symptoms; however, her serum Mg2þ was found to be low
(0.52 mmol/l). Ca2þ (2.5 mmol/l), PO4
3 (1.19 mmol/l), alkaline
phosphatase (1.51 mkat/l), and parathyroid hormone (123 pg/ml)
were in the normal range. Although the index patient was supple-
mented withMg2þ, after which a serumMg2þ level of 0.61mmol/l
was reached, a complete normalization of serum Mg2þ was not
observed. The index patient and his mother were lost for further
follow-up studies.
Mutation Analysis
Genomic DNA from peripheral blood was isolated using standard
methods. After previous exclusion of mutations in FXYD2, EGF,
and SLC12A3 (MIM 600968) (data not shown), individuals from
a Dutch family (Family A, Figure 1A, I.1, II.3, and III.2) and a family
fromtheCzechRepublic (FamilyB,Figure1A, I.2andII.1)were tested
for mutations in the coding region of CNNM2 (NM_017649.3) by
direct sequencing of amplified exonic PCR products. Primers were
designed using Primer3 software.17 Amplicons generated for
sequencing included at least 80 nucleotides upstream and 30 nucle-
otides downstream of the exonic sequence to cover possible muta-
tions in branch and splice sites. Primer sequences and PCR condi-
tions are listed in Table S1 (available online). We checked for the
absence of identified mutations in 202 and 214 ethnically matched
control chromosomes in family A and family B, respectively.
Bioinformatics
Weperformedamultiple sequencealignmentof theCNNM2protein
with its three human homologs and with six orthologs using Clus-
talW. For a prediction of the membrane topology, the following
web services were used: Human Protein Atlas, TMHMM Server v.
2.0, and Consensus Prediction of Membrane Protein Topology.
Protein signatures were determined using the InterPro database.
Antibody Generation
A guinea pig anti-CNNM2 polyclonal antibody directed against
the CNNM2-specific peptide CGLNHSDSLSRSDRI, corresponding
to amino acids 754–768 of both the human and mouse protein,
was generated by Biogenes (Berlin, Germany). In brief, guinea
pigs were injected on day 1 with 0.5 mg synthetic peptide conju-
gated with the carrier protein Limulus polyphemus hemocyanin,
and preimmune serum was withdrawn. Subsequent boosts of
1 3 0.25 mg and 3 3 0.125 mg peptide were performed on days
14, 28, 56, and 84, followed by a final bleeding on day 98. The
antibody response in the serum from the final bleeding was
compared with antibody response from the preimmune serum
from the same animal to ensure specificity (Figure S1).
Immunohistochemistry
Four percent (w/v) paraformaldehydefixed andparaffin-embedded
human kidney sections from healthy human kidneys were stained
sequentially with the antibody against CNNM2 and an antibody
against uromodulin/Tamm-Horsfall protein (UMOD [MIM
191845]), parvalbumin (PVALB [MIM 168890]), or the thiazide-
sensitiveNaþ-Cl cotransporter (NCC) (Figure 2). In short, after de-
paraffinization and rehydration, sections were blocked with 3%
(v/v) goat serumfor 20min.Afterblocking, sectionswere incubated
for 1 hr with guinea pig anti-CNNM2 antibody (1:100) in PBS/3%The Ameri(w/v) BSA. After washing, the secondary antibodies Alexa Fluor
488 or 633 goat anti-guinea pig IgG (Invitrogen, Belgium, 1:200)
in PBS/3% (v/v) goat serum were applied for 1 hr. Sections were
washed and blocked for 20 min with rabbit serum. After blocking,
sections were incubated for 1 hr with sheep anti-UMOD (Meridian
Life Sciences, 1:400), goat anti-PVALB (Santa Cruz, 1:200), or sheep
anti-T58-NCC (purchased from the University of Dundee, UK,
1:100) in PBS/3% (w/v) BSA. Afterwashing, appropriate Alexa Fluor
488 or 633 conjugated secondary antibodies (Invitrogen, 1:200) in
PBS/3% (v/v) rabbit serum were applied for 1 hr. Sections were
mounted in ProLong Gold Antifade reagent (Invitrogen) and
viewed under a Zeiss LSM 510 Meta confocal microscope (Zeiss,
Belgium). The images were analyzed with ImageJ software.
Four-micrometer-thick sections of 4% (w/v) paraformaldehyde
fixed and paraffin-embedded kidneys of C57BL/6 mice
(Figure S2) were similarly processed except that antibodies against
CNNM2 and the nephron markers were not applied sequentially.
Here, the primary antibodies were guinea pig anti-CNNM2
(1:100), rabbit anti-UMOD (Biomedical Technologies, 1:250),
and rabbit anti-NCC (a kind gift from Dr. D.H. Ellison, 1:200).
The secondary antibodies were Alexa Fluor 488 goat anti-guinea
pig IgG and Alexa Fluor 594 goat anti-rabbit IgG (both Invitrogen,
1:500). Fluorescence microscopy of these sections was performed
with a Leica DM IRE2 inverted microscope, and images were taken
with Openlab software.Cloning
To obtain CNNM2 expression constructs, we used the full-length
murine Cnnm2 cDNA, RIKEN FANTOM clone 6330543C15,
GenBank accession number AK032006.1. Compared to RefSeq
NM_033569.3, it contained two errors in its coding region
(c.560A>G [p.Lys187Arg] and c.1329delC [p.Lys444ArgfsX6],
where þ1 is the A of the translation initiation codon). These
were corrected using the QuikChange site-directed mutagenesis
kit (Stratagene) according to the manufacturer’s protocols. This
resulted in clone pFLCI-mCnnm2WT. To obtain a construct with
the missense mutation c.1703C>T (p.Thr568Ile) found in family
B, we performed another mutagenesis round, resulting in clone
pFLCI-mCnnm2Mut.
For the generation of C-terminally HA-tagged eukaryotic expres-
sion constructs, the open reading frames of the two pFLCI clones
were amplified using Phusion polymerase (Finnzymes) and
primers For1 and Rev1 (Table S2) to introduce an in-frame HA
tag before the stop codon and KpnI and XbaI restriction sites.
The amplicons were cloned into pGEM-T easy (Promega) and
subcloned into the pcDNA3 expression vector (Invitrogen) via
the KpnI and XbaI restriction sites.
For cloning of wild-type and p.Thr568Ile mutant CNNM2 in the
bicistronic-enhanced GFP expression vector pCINeo-IRES-GFP18
and introduction of an in-frame C-terminal HA tag, the open
reading frames of the two pFLCI clones were amplified using
primers For2 and Rev2 (Table S2) and cloned using NheI and
XhoI restriction sites.
All clones were sequence verified for the complete CNNM2
coding region.Immunocytochemistry
Mouse distal convoluted tubule (mDCT) cells were kindly
provided by Dr. P.A. Friedman (University of Pittsburgh School
of Medicine, Pittsburgh, PA). The isolation and functional charac-
terization of these cells has been described previously.19,20 Thecan Journal of Human Genetics 88, 333–343, March 11, 2011 335
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Figure 2. Immunohistochemical Analysis of CNNM2 in Human Kidney
(A) Staining of a human kidney section with antibodies against UMOD (left, in green) and CNNM2 (middle, in red). The merged image
on the right shows codistribution of UMOD and CNNM2 in identical nephron segments, indicating basolateral subcellular staining of
CNNM2 in the TAL. The scale bars represent 50 mm.
(B) Immunostaining for PVALB (left, in green) and CNNM2 (middle, in red) of a human kidney section. The merged image on the right
indicates codistribution of PVALB in the DCT with basolaterally localized CNNM2. The scale bars represent 50 mm.
(C) A human kidney section stained with antibodies against NCC (left, in red) and CNNM2 (middle, in green). Merging the images as
shown on the right shows that all NCC positive tubules are positive for CNNM2, indicating the presence of CNNM2 in the DCT. The
scale bars represent 50 mm.cells were grown in DMEM/Ham’s F-12 media (Lonza, Verviers,
Belgium), supplementedwith 5% (v/v) fetal bovine serum (Lonza),
2 mM L-glutamine, 50 U/ml penicillin, and 50 mg/ml strepto-
mycin in a humidified environment of 5% (v/v) CO2 at 37
C.
Where indicated, subconfluent mDCT cells were cultured in
Mg2þ- or Ca2þ-freemedia (HyClone DMEM/High glucose, Thermo
Scientific) for 18 hr. Other constituents of the Mg2þ- or Ca2þ-free
media were similar to those in the complete media. Cell passages
20–35 were used in the present study. mDCT cells were fixed
with 4% (w/v) paraformaldehyde, permeabilized (0.2% [v/v]
Triton X-100 in PBS), and blocked (3% [v/v] goat serum in PBS).
The cells were incubated with the primary antibody against
CNNM2 (1:100 in PBS/2% [w/v] BSA) for 1 hr, followed by an incu-
bation for 45 min with Alexa Fluor 488-conjugated secondary
anti-guinea pig IgG antibodies (Invitrogen, 1:200). The cells were
mounted in ProLongGold antifade reagent containing DAPI (Invi-
trogen). Cells were viewed under a Zeiss LSM 510 Meta confocal
microscope (Zeiss, Belgium). The images were analyzed with Im-
ageJ software.336 The American Journal of Human Genetics 88, 333–343, March 1Aliquots of 13106 MDCK-C7 cells21 were transfected with 2 mg
of pcDNA3 constructs expressing C-terminally HA-tagged wild-
type or p.Thr568Ile mutant CNNM2with the Amaxa Nucleofactor
Kit T (program U-023, Lonza, Cologne, Germany). Cells were
directly seeded onto filter supports (Millicell PCF 0.4 mm pore
size, effective area 0.6 cm2, Millipore, Bedford, MA) and grown
in MEM with Earle’s salts (PAA Laboratories, Pasching, Austria),
supplemented with 10% (v/v) fetal bovine serum, 100 U/ml peni-
cillin, and 100 mg/ml streptomycin (PAA) at 37C in a humidified
5% (v/v) CO2 atmosphere for 12 to 36 hr. Cells were rinsed in PBS,
fixed in methanol (20C, 10 min), permeabilized (0.5% [v/v]
Triton X-100 in PBS, 10 min), blocked (2% [v/v] goat serum in
PBS), and incubated with mouse anti-HA (Cell Signaling Tech-
nology, 1:100) and rabbit anti-occludin (Invitrogen, 1:100) anti-
bodies in blocking solution for 1 hr at 37C, followed by incuba-
tion with cy2-conjugated goat-anti-mouse and cy5-conjugated
goat anti-rabbit antibodies (both Jackson ImmunoResearch,
1:500) and 1 mM DAPI (Roche) for 45 min at 37C. Filter supports
with immunostained cells were mounted in ProTaqs Mount Fluor1, 2011
(Biocyc, Germany) for investigation under a Zeiss LSM 510 META
confocal microscope (Jena, Germany). Images and videos were
generated with LSM Image Browser software.Quantitative Real-Time PCR
mDCT cells were grown under control conditions or low-Mg2þ or
low-Ca2þ conditions for 18 hr as described above. Total RNA was
extracted via the RNAqueous-Micro kit (Ambion) according to
the manufacturer’s protocol. Quality and concentration of the iso-
lated RNA preparations were analyzed using the 2100 Bioanalyzer
(RNA Pico chip, Agilent Technologies, Palo Alto, CA). One micro-
gram of RNA was used for reverse transcription using the iScript
cDNA Synthesis Kit (Bio-Rad). Real-time PCR primers (Table S3)
were designed using Primer3 software.17 PCR reactions were per-
formed on a CFX96TM Real-Time PCR Detection System (Bio-Rad
Laboratories, Hercules, CA). Reactions were done in duplicate
using iQTM SYBR Green Supermix (Bio-Rad) with primer concen-
trations of 100 nM in 20 ml reactions. PCR conditions were 95C
for 3 min followed by 40 cycles of 15 s at 95C and 30 s at 60C.
A single PCR product accumulation was detected and the PCR
products were checked by sequencing. Relative changes in target
gene/GapdhmRNA ratio were determined by the formula 2DDCt.22
Comparable results were obtained when Actbwas used as the refer-
ence gene (data not shown).Electrophysiology
Human embryonic kidney (HEK) 293 cells seeded in 12-well plates
were transfected, via Lipofectamine 2000, (Invitrogen) with 1 mg of
pCINeo-IRES-GFP constructs encoding C-terminally HA-tagged
wild-type or p.Thr568Ile mutant CNNM2. After 12 hr, transfected
cellswereplatedat lowdensityonglass coverslips coatedwithfibro-
nectin (Roche). Cells were maintained at 37C in DMEM and sup-
plemented with 10% (v/v) fetal bovine serum, essential amino
acids, and L-glutamine in 5% (v/v) CO2 atmosphere. Patch-clamp
experiments were performed under the whole-cell configuration
with an EPC-9 patch-clamp amplifier controlled by the Pulse soft-
ware (HEKA Elektronik, Germany). Borosilicate patch pipettes
had resistances between 3 and 4 MU after they were filled with
the intracellular solutions. Series resistances (3–10 MU) were
continuously monitored with the automatic capacitance compen-
sation of Pulse software. All patch-clamp experiments were per-
formed at room temperature (21C). To study Naþ-dependent
inward currents from wild-type and mutant CNNM2-expressing
cells, we applied a repetitive voltage ramp protocol consisting of
120 to þ80 mV over 450 ms duration every 2 s from a holding
potential of 0 mV. The density current was obtained from the
peak current at110mVandwas normalizedwith the capacitance
value of the cell obtained from the set-up. Extracellular solutions
were (in mM) 80 Naþ-gluconate, 10 HEPES, 120 mannitol
(pH 7.35 adjusted with Tris), and 80 Naþ-gluconate, 20 MgSO4,
10 HEPES, 80 mannitol (pH 7.35 adjusted with Tris). The intracel-
lular solution was (in mM): 120 N-methyl-D-glucamine (NMDG),
120 2-(N-morpholino)-ethanesulfonic acid hydrate (MES), 2
MgSO4, 10 HEPES (pH 7.2 H2SO4). The analysis and display of
patch-clamp data were performed by using Igor Pro software
version 6.0 (WaveMetrics, Lake Oswego, OR, USA).Cell Surface Biotinylation and Immunoblotting
HEK293 cells were transfected with pCINeo/IRES-GFP constructs
expressing HA-tagged wild-type or p.Thr568Ile mutant CNNM2,
as described above. After 48 hr, cells surfaces were biotinylatedThe Ameriwith sulfo-NHS-LC-LC-biotin (Pierce, Rockford, IL, USA). Cells
were lysed with a Triton-containing lysis buffer, and 5% of the
protein amount was collected as a total sample. Subsequently,
the biotinylated proteins of the remaining 95% were precipitated
with NeutrAvidin-agarose beads (Pierce, Rockford, IL, USA). We
resolved total protein and plasma membrane fractions by SDS-
PAGE and analyzed CNNM2 expression by immunoblot analysis
with mouse anti-HA antibodies for the input and the plasma
membrane fraction (Cell Signaling Technology). Probing blots
with anti-b-actin antibodies (Sigma) confirmed equal loading
and the absence of cytosolic proteins in the biotinylated fraction.
Statistics
Data are expressed as the mean 5 standard error of the mean
(SEM). Data in Figure 3Awere analyzed with an unpaired Student’s
t test. Data in Figure 4C were analyzed with paired (0 versus
20 mM Mg2þ) and unpaired (wild-type versus mutant) Student’s
t tests. p values of less than 0.05 were considered significant.Results
Mutations in CNNM2 Cause Dominant
Hypomagnesemia
Here, affected individuals of two unrelated families with
dominant hypomagnesemia were tested for mutations in
CNNM2. In both families, the index patient had severely
lowered serum Mg2þ levels (0.51 mmol/l and 0.36 mmol/l
in family A and B, respectively) in the absence of other
electrolyte disturbances. Affected individuals in both fami-
lies showed an inappropriately normal urinaryMg2þ excre-
tion, demonstrating a defect in tubular reabsorption
(details in Subjects and Methods).
Mutation screening of CNNM2 (NM_017649.3) revealed
a heterozygous 1 bp deletion, c.117delG in the index
patient of family A, and a heterozygous missense mutation
c.1703C>T in the index patient of family B (Figure 1A). In
family A, the corresponding deletion was also detected in
the father (II.3) but not in the grandfather (I.1) of the index
patient. In family B, the mother (I.2) carried the same
missense mutation as the index patient. Neither of the
two mutations was found in more than 200 ethnically
matched control chromosomes.
The 1 bp deletion c.117delG (p.Ile40SerfsX15) causes
a frameshift and premature stop codon, leading to a trun-
cated protein of 53 amino acids. The missense mutation
c.1703C>T, causing a substitution of the threonine at
position 568 with an isoleucine (p.Thr568Ile), is located
in the most conserved region of CNNM2, termed ancient
conserved domain (ACD) (Figure 1B).23 A multiple se-
quence alignment of the CNNM2 protein with its three
human homologs and with six orthologs down to the
Salmonella bacterium (Figure 1C) shows that the threonine
at position 568 is highly conserved.
One nonsynonymous SNP, c.113G>A (p.Arg38Gln), was
detected in our patients. We confirmed it to be a SNP by
testing control chromosomes (n¼ 214), where it was found
seven times. Moreover, it was also listed in the NCBI data-
base of genetic variation (rs76057237, dbSNP build 131).can Journal of Human Genetics 88, 333–343, March 11, 2011 337
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Figure 3. Response to Extracellular
Mg2þ and Basolateral Localization of
CNNM2 in Cultured Cells
(A) Modulation of Cnnm2, Trpm6, and
Slc12a3 mRNA levels under low-Mg2þ or
low-Ca2þ conditions. mDCT cells showed
increased expression levels of Cnnm2 (in
red) and Trpm6 (in blue) after 18 hr growth
under low-Mg2þ (left bars) but not under
low-Ca2þ conditions (right bars) as deter-
mined by quantitative real-time PCR. The
Slc12a3 transcript (Ncc, in yellow) was
used as a positive control for low-Ca2þ
conditions. Expression levels are normal-
ized to those of Gapdh and shown as fold
change difference compared to control
conditions. n ¼ 6, data are shown as
means 5 SEM. **p < 0.01; ***p < 0.001
compared to normal culture conditions.
(B) Effect of low Mg2þ on endogenous
CNNM2 protein levels in polarized
mDCT cells as shown by immunolabeling
with antibodies against CNNM2 (in red).
After 18 hr growth under low-Mg2þ condi-
tions, mDCT cells showed increased
CNNM2 expression (bottom left) when
compared to control conditions (top left)
with identical recording settings. Predomi-
nant basolateral staining was observed in Z
stacks for both control (top right) and low-
Mg2þ conditions (bottom right). The scale
bars represent 20 mm (left) and 5 mm
(right).
(C) Confocal images of transiently trans-
fected MDCK-C7 cells with wild-type
(left) and p.Thr568Ile mutant (right)
CNNM2-HA-tagged constructs. Cells were
immunostained with antibodies against
the HA tag (in green) and costained with
antibodies against the tight junction
protein occludin (in red) as a boundary
marker between the apical and basolateral
compartment. Nuclei were counterstained
with DAPI (in blue). Wild-type and
p.Thr568Ile mutant CNNM2 showed
comparable localization to the (baso-)
lateral membrane. The scale bars represent
10 mm.CNNM2 Is Localized on the Basolateral Side
of Mg2þ-Transporting Nephron Segments
in Human and Mouse Kidney and Upregulated
under Low-Mg2þ Conditions
In view of the low serum Mg2þ levels detected in both
families, the inappropriately normal level of urinary
Mg2þ excretion pointed to a renal defect in Mg2þ reabsorp-
tion. To determine the renal localization of CNNM2, we
generated a polyclonal antibody against a CNNM2-specific
peptide. Subsequent immunohistochemistry on human
kidney sections revealed that CNNM2 is expressed in
both the thick ascending limb (TAL) of Henle’s loop
(Figure 2A), as indicated by codistribution with uromodu-
lin/Tamm-Horsfall protein, and DCT (Figures 2B and 2C),338 The American Journal of Human Genetics 88, 333–343, March 1as shown by codistribution with parvalbumin and the
thiazide-sensitive Naþ-Cl cotransporter (NCC).24,25 We
obtained similar results for mouse tissue sections by using
antibodies against uromodulin and NCC as markers for
TAL and DCT, respectively (Figure S2). The staining pattern
for CNNM2 was consistently basolateral, as confirmed
by codistribution but not colocalization with the apical
uromodulin and NCC proteins.
Cnnm2 was originally identified as a Mg2þ-responsive
gene by differential gene expression via microarray
analysis of mouse distal convoluted tubule (mDCT) cells
under control and low-Mg2þ conditions.15 We grew
mDCT cells under low-Mg2þ, low-Ca2þ, or control condi-
tions to test whether this upregulation is specific for1, 2011
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Figure 4. Electrophysiological Analysis of Wild-Type and p.Thr568Ile Mutant CNNM2
(A) Representative whole-cell current densities measured from HEK293 cells transiently transfected with expression constructs for wild-
type CNNM2 (black dots) or p.Thr568Ile mutant CNNM2 (red dots). Current traces were recorded in a bath solution containing either
20 mMMgSO4, (indicated by black bars above the graph) or 20mM ZnSO4 (gray bar) or in a Mg
2þ- and Zn2þ-free bath solution (no bars).
The solid and dotted arrows correspond to the time point of measurement in the presence or absence of extracellular Mg2þ, the results of
which are shown in (B) and (C).
(B) Representative I-V relationship traces recorded either in the presence (solid arrow, traces in black) or absence of extracellular Mg2þ
(dotted arrow, traces in gray). p.Thr568Ile mutant Naþ-evoked currents (right) were smaller under both perfusion conditions as
compared to the wild-type CNNM2 protein (left).
(C) Histogram presenting averaged current densities at 110 mVobtained from wild-type (left) and p.Thr568Ile mutant CNNM2 (right)
expressing HEK293 cells (n ¼ 16 for both) in the presence and absence of 20 mM extracellular MgSO4 (indicated by a þ or a  symbol).
Under both conditions, current amplitudes in cells expressing mutant CNNM2 were significantly smaller than those in cells expressing
wild-type CNNM2. *p < 0.05, compared to wild-type CNNM2. #p < 0.05, compared to presence of 20 mM Mg2þ. The error bars
denote SEM.
(D) Cell surface biotinylation of HEK293 cells expressing HA-tagged wild-type or p.Thr568Ile mutant CNNM2. A representative immu-
noblot shows comparable expression levels of mutant and wild-type protein on themembrane (upper blot) as well as in the total protein
fraction (lower blot).Mg2þ or could be induced by lowered Ca2þ as well,. Quan-
titative real-time PCR analysis of cDNA from these cells
showed a significant upregulation of both Cnnm2 and
Trpm6 transcripts (2.7- and 3.6-fold, respectively) under
low Mg2þ when compared to control conditions, whereas
low Ca2þ had no significant effect on Cnnm2 or Trpm6
mRNA levels (Figure 3A). Slc12a3 (Ncc) expression has
previously been shown to be upregulated under low-Ca2þ
conditions and served as a positive control.25
To further substantiate the Mg2þ-responsive Cnnm2
transcript levels and the basolateral localization of the
protein, we cultured mDCT cells and stained the cells
with the antibody against CNNM2 to detect endogenous
expression of the protein. Under normal Mg2þ conditions,
we were able to confirm the predominant basolateral
localization of the CNNM2 protein (Figure 3B) that was
increased in Mg2þ-deprived cells. Unfortunately, the anti-
body against CNNM2 has proven unsuitable for confirm-The Ameriing this result by immunoblot analysis. In addition, we
performed in vitro expression studies by transient transfec-
tion of polarized Madin-Darby canine kidney (MDCK)-C7
cells with a vector encoding HA-tagged wild-type
CNNM2. Again, we detected localization of CNNM2 at
the (baso-)lateral membrane (Figure 3C, left, and Movie
S1). To test whether the missense mutation identified in
family B affected the trafficking of the protein, we also
expressed HA-tagged p.Thr568Ile mutant CNNM2 in
MDCK-C7 cells (Figure 3C, right, and Movie S2). No
obvious difference in subcellular localization was observed
between mutant and wild-type protein.
Functional Characterization of CNNM2
and the p.Thr568Ile Mutant
Next, we investigated the functional characteristics of
CNNM2 by using patch-clamp analysis in the whole-cell
configuration of HEK293 cells that were transientlycan Journal of Human Genetics 88, 333–343, March 11, 2011 339
transfected with constructs encoding HA-tagged wild-type
CNNM2 or with mock DNA. Survival of HEK293 cells
transfected with CNNM2 could be greatly improved by
by inclusion of 20 mM MgSO4 in the culture medium.
Therefore, all cells were cultured and sealed in the presence
of MgSO4. Because Goytain and Quamme
15 observed
Mg2þ-induced currents by CNNM2 expressed in X. laevis
oocytes, we first applied a repetitive voltage ramps protocol
in the presence of an increasing extracellular Mg2þ
gradient as the sole charge carrier (2 to 40 mM). However,
neither an inward nor an outward increase in current was
observed in HEK293 cells expressing CNNM2 when these
were compared to mock transfected cells (data not shown).
Rather, in the presence of 80 mM extracellular Naþ-gluco-
nate and 20 mM MgSO4, a small Mg
2þ-sensitive Naþ
current was observed at a holding potential of 110 mV,
which was significantly and reversibly increased by
removing extracellular MgSO4 (Figure 4A, average values
shown in Figure 4C). To disclose effects on the relatively
small range currents (in the order of 20–100 pA/pF), we
used Mg2þ concentrations of 0 and 20 mM MgSO4, which
are nonphysiological but not uncommon in electrophysio-
logical experiments designed to reveal effects on such
currents. The Mg2þ-sensitive Naþ current could be com-
pletely blocked by 20 mM ZnSO4. The I-V relationship
(Figure 4B, left graph) shows a slightly inwardly rectifying
current in the absence of extracellular Mg2þ (dotted arrow,
gray trace). This current was reduced in the presence of
extracellular Mg2þ (solid arrow, black trace). We did not
observe a significant Mg2þ-sensitive Naþ current in
mock-transfected HEK293 cells (data not shown).
To characterize the effect of the p.Thr568Ile mutation on
CNNM2 activity, we applied the same protocol as described
above using a construct encoding p.Thr568Ile mutant
CNNM2 in which we sequentially applied an extracellular
solution that either contained 20 mMMgSO4 or was Mg
2þ
free. Under these experimental conditions, a significant
decrease in the basal inward Naþ current, either in the pres-
ence (solid arrow) or absence (dotted arrow) of extracellular
Mg2þ, was observed for the mutant (Figures 4A and 4B).
Specifically, initial currents in the presence of 20 mM
MgSO4 were 19.5 5 4.7 versus 5.5 5 1.4 pA/pF (mean 5
SEM, n ¼ 16), compared to currents in the absence of
extracellular Mg2þ that were 33.9 5 8.8 versus 9.9 5
2.4 pA/pF in wild-type and mutant CNNM2, respectively
(Figure 4C). In both cases, application of Zn2þ produced
a full block of the Naþ current (Figure 4A).
Wild-type and mutant CNNM2 protein were expressed
in similar amounts on the surface of the HEK293 cells as
demonstrated by a cell surface biotinylation assay followed
by immunoblot analysis (Figure 4D). Equal loading of the
blots and absence of cytosolic proteins in the biotinylated
fraction were checked by staining with antibodies against
b-actin (Figure S3). Thus, our results show that mutation
of the threonine at position 568 to isoleucine causes
a significant decrease in CNNM2 activity present at the
plasma membrane.340 The American Journal of Human Genetics 88, 333–343, March 1Discussion
Here, we have identified mutations in CNNM2 in patients
with dominant renal Mg2þ wasting. In the kidney,
CNNM2 is predominantly localized on the basolateral
side of TAL and DCT, the major Mg2þ-transporting
nephron segments. The missense mutation found in our
patients significantly impairs CNNM2 function as deter-
mined by electrophysiological analysis.
CNNM2 (cyclin M2) is a member of a family of four
proteins, CNNM1–4 (MIM 607802; 607804; 607805).23
The name results from a weak sequence similarity that is
shared with the cyclin family, although a cyclin-like func-
tion has never been shown for CNNM1–4. Within the
CNNM family, CNNM2 is the most conserved between
man and mouse, having a 99.1% similarity and 97.8%
identity on the protein level. CNNM2 has 875 amino acids
and is predicted to have four to five transmembrane
domains and an extracellular C terminus (Figure 1B). The
CNNM proteins were previously called ACD proteins
because of an evolutionarily conserved domain that shares
high homology with the bacterial CorC protein.23 Interest-
ingly, this CorC protein, together with CorA, CorB, and
CorD was found to be involved in Co2þ resistance and
Mg2þ transport in Salmonella typhimurium.26 A shared
feature within the ACD is a tandem pair of cystathionine
beta-synthase (CBS) domains (InterPro 000644) that are
thought to form intramolecular dimeric structures.27 CBS
domains have been found in the ClC family of chloride
channels and also in the bacterial Mg2þ transporter
MgtE. Not surprising, the p.Thr568Ile substitution, located
in the most conserved part of the ACD (Figure 1C), has a
strong impact on CNNM2 function, as shown by the
clearly diminished Mg2þ-sensitive Naþ currents.
Perhaps as a result of the different expression systems
used, our electrophysiology results on CNNM2 differ
from previous results of Goytain and Quamme.15 In
mammalian HEK293 cells, we observed a Mg2þ-sensitive
Naþ current rather than the mediation of Mg2þ currents
by CNNM2, as found upon expression in X. laevis oocytes.
Despite this difference, our findings underline an emerging
role for CNNM2 in renal Mg2þ handling. First, and similar
to the results of Goytain and Quamme,15 we showed that
the Cnnm2 transcript in mDCT cells is upregulated under
conditions of Mg2þ deficiency, an effect not seen under
low-Ca2þ conditions, suggesting a specific response to
extracellular Mg2þ concentrations. By using our antibody
against CNNM2, we were also able to show an elevated
protein expression. Second, analogous to the results in
mDCT cells, in Cldn16 knockout mice, which display
reduced serum Mg2þ levels, the expression of the Cnnm2
transcript in the kidney was also shown to be increased.14
Third, it has been described that in Salmonella, triple dis-
ruptant for the Mg2þ transporter genes MgtA, MgtB, and
CorA, CNNM2 was able to partly complement the Mg2þ-
dependent growth deficiency,28 again suggesting an
involvement of CNNM2 in Mg2þ transport. Finally, our1, 2011
genetic findings that mutations in CNNM2 cause domi-
nant hypomagnesemia in humans are in line with the
results of a recent genome-wide association study showing
common variants in CNNM2 to be associated with serum
Mg2þ concentrations.29 In this study, six loci, including
TRPM6, were found influencing serum Mg2þ. In a
secondary screen, the genome-wide association study
also identified common variants in CNNM2 and other
members of the CNNM gene family.
In the families with dominant Mg2þ wasting presented
here, we found two different types of mutation. In family
A, we found an early frameshift, leading to a truncated
protein of only 53 amino acids. In family B, we identified
a substitution of a highly conserved amino acid that signif-
icantly impairs the function of the protein. Still, the
affected individuals of both families display a nearly iden-
tical phenotype. Although this suggests to us that a reduced
amount of functional protein may cause the disorder, the
low number of patients does not allow us to make definite
genotype-phenotype correlations, and we cannot rule out
a dominant-negative effect. Future identification and
analysis of additional families with mutations in CNNM2
will help to clarify this point.
The biochemical findings between index patients and
affected parents do not show marked differences. Notably,
the serum Mg2þ levels in both index patients and affected
parents are in the same decreased range. What is remark-
able, however, is the variability in the age of clinical (symp-
tomatic) onset of the disease. In family A, the onset of the
disease in the index patient was at two years of age, in her
father it was at 15 years of age; in family B, the affected
mother did not show any symptoms at all. This intrafami-
liar variability in age of onset and/or severity of symptoms
is a well-known phenomenon for dominant diseases. For
example, this was also observed for other dominant hypo-
magnesemia disorders, such as the families with an FXYD2
mutation.9,30 The mechanism(s) underlying this phenom-
enon have not yet been elucidated, but it is likely that
genetic modifying factors and/or environmental factors
are involved. At present these putative genetic and envi-
ronmental predisposing risk factors are completely
unknown.
Because CNNM2 expression is not restricted to the
kidney (gene expression was reported to be ubiquitous
and the highest levels were in kidney and brain),15,23,31
we cannot exclude a contribution of other tissues to the
observed hypomagnesemia in our patients. Importantly,
however, the most prominent phenotype consists of a
renal defect in Mg2þ reabsorption, as shown by the
inability of the kidney to reduce urinary Mg2þ excretion
under low serumMg2þ conditions. A tissue-specific pheno-
type was also observed for patients with mutations in
CNNM4, a gene that is ubiquitously expressed as
well.23,31 In this case, mutations lead to Jalili syndrome
(MIM 217080), which features a phenotype restricted to
the teeth (amelogenesis imperfecta) and eyes (cone-rod
dystrophy).32,33 We hypothesize that a reduction in theThe Ameriamount of functional CNNM2 in our patients will be
most noticeable in the renal epithelia that reabsorb high
amounts of Mg2þ.
In human and mouse kidney, we observed predominant
CNNM2 expression in both TAL and DCT, the two consec-
utive nephron segments primarily responsible for Mg2þ
reabsorption.1 The DCT has been shown to be the nephron
segment controlling final plasma Mg2þ concentrations, as
exemplified by the DCT-specific expression of the Mg2þ
channel TRPM6, the apical entry pathway for active
Mg2þ transport.13 CNNM2 expression in this segment is
in line with a putative role in active Mg2þ reabsorption.
In fact, as reviewed by Glaudemans et al.,34 all proteins
involved in primary familial hypomagnesemia identified
to date, including TRPM6, Kv1.1, EGF, and the Naþ/Kþ-
ATPase g-subunit, show codistribution in this nephron
segment.
Surprisingly, we also found high levels of CNNM2
expression in TAL. This latter nephron segment has been
reported to be responsible for up to ~70% of Mg2þ reab-
sorption, via passive, paracellular transport.1 The high
expression levels of CNNM2 in this nephron segment
might either indicate a role of CNNM2 in affecting paracel-
lular Mg2þ reabsorption pathways or rekindle the debate
about the existence of an activeMg2þ reabsorption compo-
nent in (cortical) TAL, as reviewed by Quamme.35
Both in TAL and DCT, CNNM2 was found at the basolat-
eral side of the epithelium, and this basolateral localization
was confirmed for endogenous CNNM2 in mDCTcells. We
showed that the localization of CNNM2 on the basolateral
membrane was unchanged for the p.Thr568Ile mutant
when CNNM2 was transiently expressed in polarized
MDCK-C7 cells. Thus, we concluded that the missense
mutation does not influence basolateral sorting of
CNNM2 in this renal cell line.
For decades, biochemical studies have predicted that an
active extrusion mechanism in the transcellular transport
of Mg2þ must exist, either via a Mg2þ pump or a Naþ/
Mg2þ exchanger.36 However, the molecular identity of
such a transporter remains elusive. Although the finding
of CNNM2 at the basolateral membrane could suggest an
involvement in direct basolateral Mg2þ extrusion, the
Mg2þ sensitivity of the Naþ currents suggests that, in
mammalian cells, CNNM2 might contribute to a Mg2þ-
sensing mechanism rather than transporting Mg2þ itself.
The tandem pair of CBS domains located in the highly
conserved ACD might be directly involved in such a
Mg2þ-sensing mechanism. This might be comparable to
the Mg2þ-sensing mechanism of the bacterial Mg2þ trans-
porter MgtE, for which the crystal structure was recently
solved37 and in which the CBS domains might play an
important role in Mg2þ-sensing.38
In conclusion, we identified mutations in CNNM2
associated with dominant hypomagnesemia by using
a candidate gene approach. Future elucidation of the exact
mechanism by which the basolaterally localized CNNM2
protein regulates renal Mg2þ reabsorption will addcan Journal of Human Genetics 88, 333–343, March 11, 2011 341
fundamental insights to our understanding of kidney
function and potentially lead to new therapeutic options.Supplemental Data
Supplemental Data include three figures, three tables, and two
movies and can be found with this article online at http://www.
cell.com/AJHG/.Acknowledgments
The authors are grateful to themembers of the affected families for
their participation in this study. We thank D.H. Ellison and P.A.
Friedman for providing the anti-NCC antibody and the mDCT
cells, respectively. We also thank F. van Zeeland for her excellent
technical support. This work was supported by grants from the
European Community, FP7 (EUNEFRON 201590) to C.A.W.,
O.D., N.V.A.M.K., I.C.M. and D.M., and the Deutsche Forschungs-
gemeinschaft (DFG FOR721) to D.G. and D.M. In addition, O.D.
was financially supported by the Belgian agencies Fonds National
de la Recherche Scientifique and Fonds de la Recherche Scientifi-
que Me´dicale, the Fondation Alphonse and Jean Forton,
a Concerted Research Action (10/15-029), an Interuniversity
Attraction Pole (IUAP P6/05), and the programme d’excellence
Marshall DIANE convention from the Re´gion Wallonne, Belgium
(Communaute´ Franc¸aise de Belgique). C.A.W. was further sup-
ported by the Swiss National Science Foundation (3100A0-
122217). R.J.B. and J.G.H. were supported by grants of the
Netherlands Organization for Scientific Research (ZonMw
9120.6110; ZonMw 9120.8026; NWO ALW 818.02.001) and
a European Young Investigator award (EURYI) 2006.
Received: December 24, 2010
Revised: February 14, 2011
Accepted: February 17, 2011
Published online: March 10, 2011Web Resources
The URLs for data provided herein are as follows:
ClustalW, http://www.ebi.ac.uk/Tools/clustalw2
Consensus Prediction of Membrane Protein Topology, http://
topcons.net
dbSNP, http://www.ncbi.nlm.nih.gov/SNP/
Human Protein Atlas, http://www.proteinatlas.org
Interpro Database, http://www.ebi.ac.uk/interpro
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/omim/
Primer3, http://frodo.wi.mit.edu/primer3
TMHMM Server v. 2.0, http://www.cbs.dtu.dk/services/TMHMM/References
1. Quamme, G.A. (1997). Renal magnesium handling: New
insights in understanding old problems. Kidney Int. 52,
1180–1195.
2. Simon, D.B., Lu, Y., Choate, K.A., Velazquez, H., Al-Sabban, E.,
Praga, M., Casari, G., Bettinelli, A., Colussi, G., Rodriguez-
Soriano, J., et al. (1999). Paracellin-1, a renal tight junction342 The American Journal of Human Genetics 88, 333–343, March 1protein required for paracellular Mg2þ resorption. Science
285, 103–106.
3. Konrad, M., Schaller, A., Seelow, D., Pandey, A.V., Waldegger,
S., Lesslauer, A., Vitzthum, H., Suzuki, Y., Luk, J.M., Becker,
C., et al. (2006). Mutations in the tight-junction gene claudin
19 (CLDN19) are associated with renal magnesium wasting,
renal failure, and severe ocular involvement. Am. J. Hum.
Genet. 79, 949–957.
4. Hou, J., Paul, D.L., and Goodenough, D.A. (2005). Paracellin-1
and themodulation of ion selectivity of tight junctions. J. Cell
Sci. 118, 5109–5118.
5. Hou, J., Renigunta, A., Konrad, M., Gomes, A.S., Schneeberger,
E.E., Paul, D.L., Waldegger, S., and Goodenough, D.A. (2008).
Claudin-16 and claudin-19 interact and form a cation-
selective tight junction complex. J. Clin. Invest. 118, 619–628.
6. Gu¨nzel, D., Amasheh, S., Pfaffenbach, S., Richter, J.F., Kausa-
lya, P.J., Hunziker, W., and Fromm, M. (2009). Claudin-16
affects transcellular Cl- secretion in MDCK cells. J. Physiol.
587, 3777–3793.
7. Schlingmann, K.P., Weber, S., Peters, M., NiemannNejsum, L.,
Vitzthum, H., Klingel, K., Kratz, M., Haddad, E., Ristoff, E.,
Dinour, D., et al. (2002). Hypomagnesemia with secondary
hypocalcemia is caused by mutations in TRPM6, a new
member of the TRPM gene family. Nat. Genet. 31, 166–170.
8. Walder, R.Y., Landau, D., Meyer, P., Shalev, H., Tsolia, M.,
Borochowitz, Z., Boettger, M.B., Beck, G.E., Englehardt, R.K.,
Carmi, R., and Sheffield, V.C. (2002). Mutation of TRPM6
causes familial hypomagnesemia with secondary hypocal-
cemia. Nat. Genet. 31, 171–174.
9. Meij, I.C., Koenderink, J.B., van Bokhoven, H., Assink, K.F.,
Groenestege, W.T., de Pont, J.J., Bindels, R.J., Monnens, L.A.,
van den Heuvel, L.P., and Knoers, N.V. (2000). Dominant
isolated renal magnesium loss is caused by misrouting of the
Na(þ),K(þ)-ATPase gamma-subunit. Nat. Genet. 26, 265–266.
10. Groenestege,W.M., The´bault, S., van derWijst, J., van den Berg,
D., Janssen, R., Tejpar, S., van den Heuvel, L.P., van Cutsem, E.,
Hoenderop, J.G., Knoers,N.V., andBindels, R.J. (2007). Impaired
basolateral sorting of pro-EGF causes isolated recessive renal
hypomagnesemia. J. Clin. Invest. 117, 2260–2267.
11. Glaudemans, B., van der Wijst, J., Scola, R.H., Lorenzoni, P.J.,
Heister, A., van der Kemp, A.W., Knoers, N.V., Hoenderop,
J.G., and Bindels, R.J. (2009). A missense mutation in the
Kv1.1 voltage-gated potassium channel-encoding gene
KCNA1 is linked to human autosomal dominant hypomagne-
semia. J. Clin. Invest. 119, 936–942.
12. Adalat, S., Woolf, A.S., Johnstone, K.A., Wirsing, A., Harries,
L.W., Long, D.A., Hennekam, R.C., Ledermann, S.E., Rees, L.,
van’t Hoff, W., et al. (2009). HNF1B mutations associate
with hypomagnesemia and renal magnesium wasting. J. Am.
Soc. Nephrol. 20, 1123–1131.
13. Voets, T., Nilius, B., Hoefs, S., van der Kemp, A.W., Droog-
mans, G., Bindels, R.J., and Hoenderop, J.G. (2004). TRPM6
forms the Mg2þ influx channel involved in intestinal and
renal Mg2þ absorption. J. Biol. Chem. 279, 19–25.
14. Will, C., Breiderhoff, T., Thumfart, J., Stuiver, M., Kopplin, K.,
Sommer, K., Gu¨nzel, D., Querfeld, U., Meij, I.C., Shan, Q., et al.
(2010). Targeted deletion of murine Cldn16 identifies extra-
and intrarenal compensatory mechanisms of Ca2þ and Mg2þ
wasting. Am. J. Physiol. Renal. Physiol. 298, F1152–F1161.
15. Goytain, A., and Quamme, G.A. (2005). Functional character-
ization of ACDP2 (ancient conserved domain protein), a diva-
lent metal transporter. Physiol. Genomics 22, 382–389.1, 2011
16. Meij, I.C., van den Heuvel, L.P., Hemmes, S., van der Vliet,
W.A., Willems, J.L., Monnens, L.A., and Knoers, N.V. (2003).
Exclusion of mutations in FXYD2, CLDN16 and SLC12A3 in
two families with primary renal Mg2þ loss. Nephrol. Dial.
Transplant. 18, 512–516.
17. Rozen, S., and Skaletsky, H. (2000). Primer3 on the WWW for
general users and for biologist programmers. Methods Mol.
Biol. 132, 365–386.
18. Trouet, D., Nilius, B., Voets, T., Droogmans, G., and Egger-
mont, J. (1997). Use of a bicistronic GFP-expression vector
to characterise ion channels after transfection in mammalian
cells. Pflugers Arch. 434, 632–638.
19. Pizzonia, J.H., Gesek, F.A., Kennedy, S.M., Coutermarsh, B.A.,
Bacskai, B.J., and Friedman, P.A. (1991). Immunomagnetic
separation, primary culture, and characterization of cortical
thick ascending limb plus distal convoluted tubule cells
from mouse kidney. In Vitro Cell. Dev. Biol. 27A, 409–416.
20. Dai, L.J., Ritchie, G., Kerstan, D., Kang, H.S., Cole, D.E., and
Quamme, G.A. (2001). Magnesium transport in the renal
distal convoluted tubule. Physiol. Rev. 81, 51–84.
21. Gekle, M., Wu¨nsch, S., Oberleithner, H., and Silbernagl, S.
(1994). Characterization of two MDCK-cell subtypes as
a model system to study principal cell and intercalated cell
properties. Pflugers Arch. 428, 157–162.
22. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative
gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods 25, 402–408.
23. Wang, C.Y., Shi, J.D., Yang, P., Kumar, P.G., Li, Q.Z., Run, Q.G.,
Su, Y.C., Scott, H.S., Kao, K.J., and She, J.X. (2003). Molecular
cloning and characterization of a novel gene family of four
ancient conserved domain proteins (ACDP). Gene 306, 37–44.
24. Dahan, K., Devuyst, O., Smaers, M., Vertommen, D., Loute,
G., Poux, J.M., Viron, B., Jacquot, C., Gagnadoux, M.F., Chau-
veau, D., et al. (2003). A cluster of mutations in the UMOD
gene causes familial juvenile hyperuricemic nephropathy
with abnormal expression of uromodulin. J. Am. Soc. Neph-
rol. 14, 2883–2893.
25. Belge, H., Gailly, P., Schwaller, B., Loffing, J., Debaix, H.,
Riveira-Munoz, E., Beauwens, R., Devogelaer, J.P., Hoenderop,
J.G., Bindels, R.J., and Devuyst, O. (2007). Renal expression of
parvalbumin is critical for NaCl handling and response to
diuretics. Proc. Natl. Acad. Sci. USA 104, 14849–14854.
26. Gibson, M.M., Bagga, D.A., Miller, C.G., and Maguire, M.E.
(1991). Magnesium transport in Salmonella typhimurium:
The influence of new mutations conferring Co2þ resistance
on the CorA Mg2þ transport system. Mol. Microbiol. 5,
2753–2762.The Ameri27. Ignoul, S., and Eggermont, J. (2005). CBS domains: Structure,
function, and pathology in human proteins. Am. J. Physiol.
Cell Physiol. 289, C1369–C1378.
28. Sponder, G., Svidova, S., Schweigel, M., Vormann, J., and
Kolisek, M. (2010). Splice-variant 1 of the ancient domain
protein 2 (ACDP2) complements the magnesium-deficient
growth phenotype of Salmonella enterica sv. typhimurium
strain MM281. Magnes. Res. 23, 105–114.
29. Meyer, T.E., Verwoert, G.C., Hwang, S.J., Glazer, N.L., Smith,
A.V., van Rooij, F.J., Ehret, G.B., Boerwinkle, E., Felix, J.F., Leak,
T.S., et al; Genetic Factors for Osteoporosis Consortium; Meta
Analysis of Glucose and Insulin Related Traits Consortium.
(2010). Genome-wide association studies of serummagnesium,
potassium, and sodium concentrations identify six Loci influ-
encing serummagnesium levels. PLoS Genet. 6, e1001045.
30. Meij, I.C., Saar, K., van denHeuvel, L.P., Nuernberg, G., Vollmer,
M., Hildebrandt, F., Reis, A., Monnens, L.A., and Knoers, N.V.
(1999). Hereditary isolated renal magnesium loss maps to chro-
mosome 11q23. Am. J. Hum. Genet. 64, 180–188.
31. Wang, C.Y., Yang, P., Shi, J.D., Purohit, S., Guo, D., An, H., Gu,
J.G., Ling, J., Dong, Z., and She, J.X. (2004). Molecular cloning
and characterization of the mouse Acdp gene family. BMC
Genomics 5, 7.
32. Polok, B., Escher, P., Ambresin, A., Chouery, E., Bolay, S.,
Meunier, I., Nan, F., Hamel, C., Munier, F.L., Thilo, B., et al.
(2009). Mutations in CNNM4 cause recessive cone-rod
dystrophy with amelogenesis imperfecta. Am. J. Hum. Genet.
84, 259–265.
33. Parry, D.A., Mighell, A.J., El-Sayed, W., Shore, R.C., Jalili, I.K.,
Dollfus, H., Bloch-Zupan, A., Carlos, R., Carr, I.M., Downey,
L.M., et al. (2009).Mutations inCNNM4cause Jalili syndrome,
consisting of autosomal-recessive cone-rod dystrophy and
amelogenesis imperfecta. Am. J. Hum. Genet. 84, 266–273.
34. Glaudemans,B.,Knoers,N.V.,Hoenderop, J.G., andBindels, R.J.
(2010).Newmolecular players facilitatingMg(2þ) reabsorption
in the distal convoluted tubule. Kidney Int. 77, 17–22.
35. Quamme, G.A. (1989). Control of magnesium transport in the
thick ascending limb. Am. J. Physiol. 256, F197–F210.
36. Schweigel, M., and Martens, H. (2000). Magnesium transport
in the gastrointestinal tract. Front. Biosci. 5, D666–D677.
37. Hattori, M., Tanaka, Y., Fukai, S., Ishitani, R., and Nureki, O.
(2007). Crystal structure of the MgtE Mg2þ transporter.
Nature 448, 1072–1075.
38. Ishitani, R., Sugita, Y., Dohmae, N., Furuya, N., Hattori, M.,
and Nureki, O. (2008). Mg2þ-sensing mechanism of Mg2þ
transporter MgtE probed by molecular dynamics study. Proc.
Natl. Acad. Sci. USA 105, 15393–15398.can Journal of Human Genetics 88, 333–343, March 11, 2011 343
